CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-09 | Imam Tariq SVP, Bus Dev, General Counsel | Grant or award | +15,000 | 39,579 | ||
| 2026-01-09 | Imam Tariq SVP, Bus Dev, General Counsel | Shares withheld for taxes | −1,401 | $1.97 | $3K | 38,178 |
| 2026-01-09 | Imam Tariq SVP, Bus Dev, General Counsel | Shares withheld for taxes | −840 | $1.97 | $2K | 37,338 |
| 2026-01-09 | Imam Tariq SVP, Bus Dev, General Counsel | Shares withheld for taxes | −747 | $1.97 | $1K | 36,591 |
| 2026-01-09 | Imam Tariq SVP, Bus Dev, General Counsel | Shares withheld for taxes | −513 | $1.97 | $1K | 36,078 |
| 2026-01-09 | Imam Tariq SVP, Bus Dev, General Counsel | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2026-01-09 | Nisco James SVP, Fin/Treas, Chief Actg Off | Grant or award | +15,000 | 38,491 | ||
| 2026-01-09 | Nisco James SVP, Fin/Treas, Chief Actg Off | Shares withheld for taxes | −2,131 | $1.97 | $4K | 36,360 |
| 2026-01-09 | Nisco James SVP, Fin/Treas, Chief Actg Off | Shares withheld for taxes | −2,131 | $1.97 | $4K | 34,229 |
| 2026-01-09 | Nisco James SVP, Fin/Treas, Chief Actg Off | Shares withheld for taxes | −1,137 | $1.97 | $2K | 33,092 |
| 2026-01-09 | Nisco James SVP, Fin/Treas, Chief Actg Off | Shares withheld for taxes | −781 | $1.97 | $2K | 32,311 |
| 2026-01-09 | Nisco James SVP, Fin/Treas, Chief Actg Off | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2026-01-09 | Buck Kristen K EVP, R&D and CMO | Grant or award | +25,000 | 104,794 | ||
| 2026-01-09 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −2,982 | $1.97 | $6K | 101,812 |
| 2026-01-09 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −2,982 | $1.97 | $6K | 98,830 |
| 2026-01-09 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −3,221 | $1.97 | $6K | 95,609 |
| 2026-01-09 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −2,147 | $1.97 | $4K | 93,462 |
| 2026-01-09 | Buck Kristen K EVP, R&D and CMO | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2026-01-09 | Flowers Cynthia Louise Director | Grant or award | +30,456 | 95,446 | ||
| 2026-01-09 | BROWN GREGORY B Director | Grant or award | +30,456 | 95,659 |
Page 1 of 18 · 345 trades